IGC Pharma, Inc.

IGC · AMEX
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$2-$2-$1-$2
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC-$0-$0-$0-$0
Other Non-Cash-$0-$0$0$0
Operating Cash Flow-$2-$1-$1-$1
Investing Activities
PP&E Inv.-$0-$0-$0-$0
Net Acquisitions-$0$0$0$0
Inv. Purchases-$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$1-$0-$0
Investing Cash Flow-$0$1-$0-$0
Financing Activities
Debt Repay.-$0-$0$0-$0
Stock Issued$3$1$1$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0-$0$0
Financing Cash Flow$3$1$1$0
Forex Effect$0$0$0$0
Net Chg. in Cash$1$0-$0-$1
Supplemental Information
Beg. Cash$0$0$0$2
End Cash$1$0$0$0
Free Cash Flow-$2-$2-$1-$1